3 Results for "

PIM-1/HDAC inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "PIM-1/HDAC inhibitors" in MCE Product Catalog:

Cat. No.: HY-174302
CAS No.: 3103925-33-0
Target:  

Pim HDAC PARP Apoptosis

Research Areas:  

Cancer

PIM-1/HDAC-IN-2 is a robust PIM/HDAC inhibitor (IC50 = 0.11 μM in MV4-11cells), which exerts a synergistic antiproliferative effect through a dual mechanism of inhibiting PIM1 kinase and selectively inhibiting HDAC6. PIM-1/HDAC-IN-2 induces cell apoptosis. PIM-1/HDAC-IN-2 remarkably induces the cleavage of PARP, thereby initiating the arrest of the cell cycle in G1 phase and a reduction in S phase. PIM-1/HDAC-IN-2 demonstrates significant anticancer efficacyin the MV4-11 xenograft model without notable toxicity[1].
loading...
    loading...
Cat. No.: HY-143233
CAS No.: 2897622-19-2
Target:  

Pim HDAC Apoptosis

Research Areas:  

Cancer

PIM-1/HDAC-IN-1 (compound 4d) is a PIM-1 inhibitor, with an IC50 of 343.87 nM. PIM-1/HDAC-IN-1 has strong inhibitory activity and selectivity against HDAC 1 and HDAC 6, with IC50 values of 63.65 and 62.39 nM, respectively. PIM-1/HDAC-IN-1 exhibits apoptosis inducing potential in MCF-7 cell lines. PIM-1/HDAC-IN-1 shows pre-G1 apoptosis and cell cycle arrest at G2/M phase .
loading...
    loading...
Cat. No.: HY-189297
Target:  

Drug Derivative HDAC Pim

Research Areas:  

Neurological Disease Cancer

HDAC8/PIM1-IN-1 is a synthetic multi-target-directed ligand (MTDL) derived from 2-ureido-6-nitrobenzamide, and computational simulations predict it to be a dual-target inhibitor of HDAC8 and PIM1. HDAC8/PIM1-IN-1 holds potential for applications in research related to cancer and neurodegenerative diseases .
loading...
    loading...